| Association of anemia with venous thromboembolism in acutely ill hospitalized patients: an APEX trial substudy G Chi, CM Gibson, AF Hernandez, RD Hull, SHA Kazmi, A Younes, ... The American journal of medicine 131 (8), 972. e1-972. e7, 2018 | 55 | 2018 |
| Cholesterol efflux capacity and its association with adverse cardiovascular events: a systematic review and meta-analysis JJ Lee, G Chi, C Fitzgerald, SHA Kazmi, A Kalayci, S Korjian, D Duffy, ... Frontiers in cardiovascular medicine 8, 774418, 2021 | 51 | 2021 |
| ApoA-I infusion therapies following acute coronary syndrome: Past, present, and future A Kalayci, CM Gibson, PM Ridker, SD Wright, BA Kingwell, S Korjian, ... Current atherosclerosis reports 24 (7), 585-597, 2022 | 21 | 2022 |
| Most promising therapies in interventional cardiology M Kerneis, T Nafee, MK Yee, HA Kazmi, S Datta, M Zeitouni, MK Afzal, ... Current Cardiology Reports 21, 1-8, 2019 | 21 | 2019 |
| Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID‐19: Network meta‐analysis of randomized controlled trials G Chi, S Memar Montazerin, JJ Lee, SHA Kazmi, F Shojaei, C Fitzgerald, ... Journal of medical virology 93 (12), 6737-6749, 2021 | 16 | 2021 |
| CSL112 (apolipoprotein AI [human]) strongly enhances plasma Apoa-I and cholesterol efflux capacity in post-acute myocardial infarction patients: a PK/PD substudy of the AEGIS-I … CM Gibson, SHA Kazmi, S Korjian, G Chi, AT Phillips, SM Montazerin, ... Journal of Cardiovascular Pharmacology and Therapeutics 27, 10742484221121507, 2022 | 15 | 2022 |
| Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention M Kerneis, U Talib, T Nafee, Y Daaboul, S Pahlavani, A Pitliya, ... Progress in Cardiovascular Diseases 60 (4-5), 524-530, 2018 | 14 | 2018 |
| Hypothyroidism causing pericardial effusion: a case report S Mirwais, SH Kazmi, SI Hussain, M Mirwais, A Sharma Cureus 11 (12), 2019 | 12 | 2019 |
| Biological basis and proposed mechanism of action of CSL112 (apolipoprotein AI [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction S Korjian, SHA Kazmi, G Chi, A Kalayci, JJ Lee, U Talib, SD Wright, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (4), 387-398, 2023 | 10 | 2023 |
| Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: meta‐analysis of phase III studies and implications on trial design G Chi, JJ Lee, SHA Kazmi, C Fitzgerald, S Memar Montazerin, A Kalayci, ... Clinical Cardiology 45 (3), 299-307, 2022 | 10 | 2022 |
| Reduction of cardiovascular mortality and ischemic events in acute medically ill patients: an APEX Substudy T Nafee, CM Gibson, MK Yee, M Kerneis, Y Daaboul, S Korjian, G Chi, ... Circulation 139 (9), 1234-1236, 2019 | 8 | 2019 |
| Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism T Nafee, CM Gibson, MK Yee, F Alkhalfan, G Chi, R Travis, M Mir, ... Expert review of cardiovascular therapy 16 (11), 845-855, 2018 | 6 | 2018 |
| AI Framework for Fetal Health Risk Prediction K Parvataneni, SH Zaidi, F Kazmi, SHA Kazmi 2023 5th International Conference on Bio-engineering for Smart Technologies …, 2023 | 5 | 2023 |
| The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives SHA Kazmi, S Datta, G Chi, T Nafee, M Yee, A Kalia, S Sharfaei, ... Medical Devices: Evidence and Research, 1-12, 2020 | 4 | 2020 |
| ASSOCIATION OF CHOLESTEROL EFFLUX CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES-A META-ANALYSIS JJ Lee, G Chi, C Fitzgerald, SHA Kazmi, A Kalayci, S Korjian, AT Phillips, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 1486-1486, 2021 | 2 | 2021 |
| Multi-Electrode Plasma Torch Characterization for Rapid Wound Healing and Sterilization B Bellannagari, SHA Kazmi, SH Zaidi Plasma Medicine 11 (4), 2021 | 2 | 2021 |
| Commentary: Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy A Pitliya, A Ahmad, H Shaukat, E Ghaffarpasand, S Sharfaei, F Kahe, ... Journal of Lung Health and Diseases 2 (3), 2018 | 2 | 2018 |
| Association of Cholesterol Efflux Capacity with Adverse Cardiovascular Outcomes: A Meta-Analysis JJ Lee, G Chi, C Fitzgerald, SH Kazmi, S Korjian, D Duffy, A Shaunik, ... Journal of Clinical Lipidology 16 (1), e1-e2, 2022 | 1 | 2022 |
| EARLY AND LATE RECURRENT CARDIOVASCULAR RISK IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME-META-ANALYSIS AND IMPLICATIONS IN TRIAL DESIGN G Chi, JJ Lee, SHA Kazmi, C Fitzgerald, SM Montazerin, A Kalayci, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 137-137, 2021 | 1 | 2021 |
| Paradoxical protective effect of obesity on the risk of venous thromboembolism: observations from apex trial AK Karabay, CM Gibson, G Chi, F Alkhalfan, A Pitliya, SS Walia, T Nafee, ... Journal of the American College of Cardiology 73 (9S1), 1944-1944, 2019 | 1 | 2019 |
